These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9589046)
41. Flow cytometric studies on the relationship between DNA content and clinicopathologic features of pancreatic cancers. Bocsi J; Berczi C; Balázs G; Lapis K Anticancer Res; 1998; 18(3A):1839-43. PubMed ID: 9673413 [TBL] [Abstract][Full Text] [Related]
42. Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: statistical, neural network and fuzzy approaches. Seker H; Odetayo MO; Petrovic D; Naguib RN; Bartoli C; Alasio L; Lakshmi MS; Sherbet GV Anticancer Res; 2002; 22(1A):433-8. PubMed ID: 12017328 [TBL] [Abstract][Full Text] [Related]
43. Analysis of leukemic cell activity with a simple acridine orange staining method. Urashima M; Hoshi Y; Akatsuka J Int J Hematol; 1992 Dec; 56(3):197-204. PubMed ID: 1282379 [TBL] [Abstract][Full Text] [Related]
44. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related]
45. Nucleic acid flow cytometry in large cell lymphoma. McLaughlin P; Osborne BM; Johnston D; Jennings P; Butler JJ; Cabanillas F; Barlogie B Cancer Res; 1988 Nov; 48(22):6614-9. PubMed ID: 3180071 [TBL] [Abstract][Full Text] [Related]
46. [An analysis of the cellular DNA contents in lung-metastasized stomach cancers]. Umehara Y; Miyahara T; Yoshida M; Oba N; Matsuda T; Gotou H; Harada Y Gan No Rinsho; 1990 Mar; 36(4):469-72. PubMed ID: 2319690 [TBL] [Abstract][Full Text] [Related]
47. Role of DNA ploidy analysis in endometrial adenocarcinoma. Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854 [TBL] [Abstract][Full Text] [Related]
48. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
49. Characterization of hematologic malignancies by flow cytometry. Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871 [TBL] [Abstract][Full Text] [Related]
50. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients]. Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437 [TBL] [Abstract][Full Text] [Related]
51. Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer. Puntoni M; Zanardi S; Branchi D; Bruno S; Curotto A; Varaldo M; Bruzzi P; Decensi A Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):979-83. PubMed ID: 17507625 [TBL] [Abstract][Full Text] [Related]
52. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982 [TBL] [Abstract][Full Text] [Related]
53. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824 [TBL] [Abstract][Full Text] [Related]
54. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma. Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138 [TBL] [Abstract][Full Text] [Related]
55. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer. Shyr YM; Su CH; Li AF; Wu CW; Lui WY Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384 [TBL] [Abstract][Full Text] [Related]
56. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis. Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394 [TBL] [Abstract][Full Text] [Related]
57. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients. Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594 [TBL] [Abstract][Full Text] [Related]
58. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study. Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284 [TBL] [Abstract][Full Text] [Related]
59. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up. el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951 [TBL] [Abstract][Full Text] [Related]